Oncodesign Precision Med... Quote - ALOPM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.732

Bid

0.73

Ask

0.75

Volume

2,803

0.732 Day's Range 0.77

0.714 52 Week Range 2.06

Market Cap

13.316M

Previous Close

0.778

Open

0.77

Last Trade

108

0.732

Last Trade Time

09:07:23

Financial Volume

VWAP

Average Volume (3m)

7,729

Shares Outstanding

18,190,878

Dividend Yield

PE Ratio

-1.64

Earnings Per Share (EPS)

-0.44

Revenue

1.08M

Net Profit

-8.09M

Sector

Electromedical Apparatus

Industry

Electromedical Apparatus

Website

www.oncodesign.com

Headquarters

Dijon, Cote-d'or, Fra

Founded

Oncodesign Precision Medicine SA is listed in the Electromedical Apparatus sector of the Euronext with ticker ALOPM. The last closing price for Oncodesign Precision Med... was 0.78 €. Over the last year, Oncodesign Precision Med... shares have traded in a share price range of 0.714 € to 2.06 €.

Oncodesign Precision Med... currently has 18,190,878 shares outstanding. The market capitalization of Oncodesign Precision Med... is 14.15 € million. Oncodesign Precision Med... has a price to earnings ratio (PE ratio) of -1.64.

Oncodesign Precision Medicine reprend les droits sur son programme OPM-201 auprès de Servier après une phase I volontaires sains positive

Reprise par OPM de l’intégralité des droits du programme OPM-201 et du portefeuille de brevets associé Confirmation de l’innocuité de la molécule chez les volontaires sains Regulatory News:...

OPM détaille les résultats finaux de son étude de phase 1 avec OPM-101, inhibiteur de la cible RIPK2, avec des données de sécurité solides sans toxicité cardiaque, ouvrant la voie au lancement de la phase 1b/2a

Finalisation du rapport d’étude de l’essai de phase 1 de l’OPM-101 contrôlé par placebo en double aveugle chez 104 volontaires sains (VS) ayant reçu OPM-101 L’analyse des ECG enregistrés sur 24h...

OPM Announces Poster Presentation on OPM-101, a RIPK2 Kinase Inhibitor, in Healthy Volunteers at UEG Week 2024 Conference

Presentation by Professor Laurent Peyrin-Biroulet (M.D., PhD Professor of Gastroenterology at CHRU of Nancy) and Bruno Robin (PharmD, Head of OPM Clinical Development) of safety, pharmacokinetic...

OPM annonce ses résultats du premier semestre 2024 et fait le point sur ses développements cliniques, et sa situation financière

OPM-101 conclut positivement sa Phase 1 volontaires sains permettant de prévoir le démarrage d'un essai clinique de Phase 1b/2a, fin 2024 début 2025 OPM-201, licenciée à Servier dans la maladie...

OPM Announces Positive Results of Its Phase 1 in Healthy Volunteers with OPM-101: Strong Target Engagement With Excellent Safety Profile

End of double-blind, placebo-controlled phase 1 trial with OPM-101: 104 healthy volunteers (VS) participated in this trial designed to assess the safety of OPM-101 in humans Very good safety...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.038	-4.93506493506	0.77	0.798	0.714	10155	0.75384156	DE
4	-0.288	-28.2352941176	1.02	1.03	0.714	13387	0.88320465	DE
12	-0.563	-43.4749034749	1.295	1.35	0.714	7729	1.01172912	DE
26	-0.258	-26.0606060606	0.99	1.38	0.714	10607	1.10009511	DE
52	-1.138	-60.8556149733	1.87	2.06	0.714	11370	1.23922383	DE
156	-0.258	-26.0606060606	0.99	2.39	0.714	10617	1.44830531	DE
260	-0.258	-26.0606060606	0.99	2.39	0.714	10617	1.44830531	DE

ALOPM - Frequently Asked Questions (FAQ)

What is the current Oncodesign Precision Med... share price?

The current share price of Oncodesign Precision Med... is 0.732 €

How many Oncodesign Precision Med... shares are in issue?

Oncodesign Precision Med... has 18,190,878 shares in issue

What is the market cap of Oncodesign Precision Med...?

The market capitalisation of Oncodesign Precision Med... is EUR 14.15M

What is the 1 year trading range for Oncodesign Precision Med... share price?

Oncodesign Precision Med... has traded in the range of 0.714 € to 2.06 € during the past year

What is the PE ratio of Oncodesign Precision Med...?

The price to earnings ratio of Oncodesign Precision Med... is -1.64

What is the cash to sales ratio of Oncodesign Precision Med...?

The cash to sales ratio of Oncodesign Precision Med... is 12.31

What is the reporting currency for Oncodesign Precision Med...?

Oncodesign Precision Med... reports financial results in EUR

What is the latest annual turnover for Oncodesign Precision Med...?

The latest annual turnover of Oncodesign Precision Med... is EUR 1.08M

What is the latest annual profit for Oncodesign Precision Med...?

The latest annual profit of Oncodesign Precision Med... is EUR -8.09M

What is the registered address of Oncodesign Precision Med...?

The registered address for Oncodesign Precision Med... is 18 RUE JEAN MAZEN, DIJON, COTE-D'OR, 21000

What is the Oncodesign Precision Med... website address?

The website address for Oncodesign Precision Med... is www.oncodesign.com

Which industry sector does Oncodesign Precision Med... operate in?

Oncodesign Precision Med... operates in the ELECTROMEDICAL APPARATUS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAAAlan Allman Associates	6.80 € (36.00%)	9.01k
ALBOOBOOSTHEAT	0.138 € (25.45%)	910
AZRNAzerion Group NV	1.44 € (24.14%)	519.71k
ABAb Science	1.118 € (23.26%)	419.35k
EEMElectricite et Eaux de Madagascar	4.00 € (16.96%)	100
DMSBSDiagnostic Medical Systems	0.003 € (-60.00%)	111
TMBSZTME Pharma NV	0.0102 € (-49.00%)	112
EIFDSTour Eiffel DS	0.002 € (-37.50%)	723.94k
MLCOTCoretech 5	0.0075 € (-31.82%)	1,000
ALTROTronic s Microsystems	4.02 € (-26.24%)	7
ATOAtos SE	0.0024 € (0.00%)	655.97M
BCPBanco Comercial Portugues SA	0.47 € (1.67%)	70.07M
ALCYBCybergun	0.0001 € (0.00%)	18.8M
ALVERVergnet	0.002 € (0.00%)	12.28M
ALHPIHopium SA	0.005 € (2.04%)	11.37M